Item 2.02 Results of Operations and Financial Condition. On October 29, 2025 , MiMedx Group, Inc. (the “ Company ”), issued a press release (the “ Earnings Press Release ”) announcing its results for the quarter that ended September 30, 2025. A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 2.02, “Results of Operations and Financial Condition”, including Exhibit 99.1 attached hereto, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or otherwise subject to the liabilities of that section. It may only be incorporated by reference into another filing under the Exchange Act or Securities Act of 1933, as amended (the “ Securities Act ”), if such subsequent filing specifically references this Form 8-K. All information in the Earnings Press Release speaks as of the date thereof and the Company does not assume any obligation to update such information in the future. In addition, the Company disclaims any inference regarding the materiality of such information which otherwise may arise as a result of its furnishing such information under Item 2.02 of this report on Form 8-K.
MDXG Mimedx Group, Inc. - 8-K
Accession
0001376339-25-0001042.027.019.01
Item 2.02 - Results of Operations and Financial Condition
Earnings press release item. The actual results are typically in Exhibit 99.1 - fetch may not have completed.
Item 7.01 - Regulation FD Disclosure
182 words
Item 7.01 Regulation FD Disclosure. On October 29, 2025 , at 4:30 PM Eastern Daylight Time, the Company intends to host a conference call and webcast (the “ Earnings Call ”) to discuss its financial and operating results for the quarter that ended September 30, 2025. A copy of the slide presentation to be used by the Company in connection with the Earnings Call is attached hereto as Exhibit 99.2 and is incorporated herein by reference. A copy of the investor presentation materials made available to the investors by the Company on the Company’s website in connection with the Earnings Release is furnished as Exhibit 99.3 to this Current Report and is incorporated herein by reference. The foregoing information is furnished pursuant to Item 7.01, including Exhibits 99.2 and 99.3 attached hereto, and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section. It may only be incorporated by reference into another filing under the Exchange Act or Securities Act if such subsequent filing specifically references this Form 8-K.
Item 9.01 - Financial Statements and Exhibits
50 words
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Earnings Press Release dated October 29, 2025 99.2 Earnings Call Presentation dated October 29, 2025 99.3 Investor Presentation dated October 2025 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.